| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
82,625,000 |
| Market
Cap: |
187.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.59 - $8.14 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
223,100 |
223,100 |
223,100 |
| Total Sell Value |
$0 |
$449,770 |
$449,770 |
$449,770 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
1 |
1 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Watler Peter K. |
Chief Technical Officer |
• – – |
2016-08-08 |
4 |
OE |
$2.08 |
$83,352 |
D/D |
40,000 |
40,000 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – – |
2016-08-08 |
4 |
S |
$29.84 |
$2,986,216 |
I/I |
(100,000) |
361,594 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2016-08-05 |
4 |
S |
$28.78 |
$719,500 |
I/I |
(25,000) |
461,594 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2016-08-04 |
4 |
S |
$27.87 |
$664,488 |
I/I |
(23,600) |
486,594 |
|
- |
|
| Herman Alan C. |
Chief Scientific Officer |
• – – |
2016-08-01 |
4 |
AS |
$25.54 |
$289,433 |
D/D |
(11,333) |
186,782 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-21 |
4 |
AS |
$26.05 |
$104,272 |
D/D |
(3,991) |
0 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-21 |
4 |
OE |
$2.08 |
$8,316 |
D/D |
3,991 |
3,991 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-20 |
4 |
AS |
$25.00 |
$593,525 |
I/I |
(23,741) |
0 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-20 |
4 |
OE |
$1.42 |
$33,641 |
I/I |
23,741 |
23,741 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-20 |
4 |
AS |
$25.02 |
$1,251,210 |
D/D |
(50,000) |
0 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-20 |
4 |
OE |
$2.08 |
$104,190 |
D/D |
50,000 |
50,000 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-11 |
4 |
AS |
$20.02 |
$870,931 |
I/I |
(43,495) |
0 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-07-11 |
4 |
OE |
$2.08 |
$90,635 |
I/I |
43,495 |
43,495 |
|
- |
|
| Viret Jean-Frederic |
Chief Financial Officer |
• – – |
2016-07-06 |
4 |
OE |
$13.50 |
$25,988 |
D/D |
1,925 |
2,325 |
|
- |
|
| Herman Alan C. |
Chief Scientific Officer |
• – – |
2016-07-01 |
4 |
AS |
$16.89 |
$71,775 |
D/D |
(4,250) |
198,115 |
|
- |
|
| Herman Alan C. |
Chief Scientific Officer |
• – – |
2016-06-01 |
4 |
AS |
$18.67 |
$79,360 |
D/D |
(4,250) |
202,365 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-05-17 |
4 |
AS |
$20.00 |
$240,000 |
I/I |
(12,000) |
0 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-05-17 |
4 |
OE |
$2.08 |
$25,006 |
I/I |
12,000 |
12,000 |
|
- |
|
| Herman Alan C. |
Chief Scientific Officer |
• – – |
2016-05-02 |
4 |
AS |
$19.13 |
$81,592 |
D/D |
(4,250) |
206,615 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-05-02 |
4 |
AS |
$20.00 |
$29,860 |
I/I |
(1,493) |
0 |
|
- |
|
| Watler Peter K. |
Chief Technical Officer |
• – – |
2016-05-02 |
4 |
OE |
$2.08 |
$3,111 |
I/I |
1,493 |
1,493 |
|
- |
|
| Herman Alan C. |
Chief Scientific Officer |
• – – |
2016-04-01 |
4 |
AS |
$21.20 |
$90,763 |
D/D |
(4,250) |
210,865 |
|
- |
|
| Viret Jean-Frederic |
Chief Financial Officer |
• – – |
2016-03-28 |
4 |
OE |
$13.50 |
$5,400 |
D/D |
400 |
400 |
|
- |
|
| Herman Alan C. |
Chief Scientific Officer |
• – – |
2016-03-02 |
4 |
AS |
$15.32 |
$92,121 |
D/D |
(6,015) |
215,115 |
|
- |
|
| Herman Alan C. |
Chief Scientific Officer |
• – – |
2016-03-01 |
4 |
AS |
$15.00 |
$7,276 |
D/D |
(485) |
221,130 |
|
- |
|
312 Records found
|
|
Page 10 of 13 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.10 (4.61%) 
